PHS
SYK icon

PFM Health Sciences’s Stryker SYK Stock Holding History

PFM Health Sciences’s Portfolio SYK Stock Details SYK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8M Buy
56,637
+34,680
+158% +$10.9M 1.53% 17
2026
Q1 		$7.21M Sell
21,957
-28,895
-57% -$10.4M 0.66% 50
2025
Q4 		$17.9M Buy
+50,852
New +$18.5M 1.78% 20
2025
Q1 		– Sell
-32,349
Closed -$11.6M – 88
2024
Q4 		$11.6M Sell
32,349
-34,665
-52% -$12.8M 0.72% 38
2024
Q3 		$24.2M Sell
67,014
-47,283
-41% -$16.3M 1.37% 26
2024
Q2 		$38.9M Buy
114,297
+59,205
+107% +$20.1M 1.92% 16
2024
Q1 		$19.7M Sell
55,092
-3,537
-6% -$1.19M 0.93% 39
2023
Q4 		$17.6M Buy
58,629
+46,523
+384% +$13.1M 1.05% 33
2023
Q3 		$3.31M Sell
12,106
-122,916
-91% -$35.2M 0.16% 66
2023
Q2 		$41.2M Buy
+135,022
New +$39M 1.6% 29
2019
Q4 		– Sell
-207,887
Closed -$45M – 76
2019
Q3 		$45M Sell
207,887
-220,962
-52% -$47.4M 1.33% 32
2019
Q2 		$88.2M Sell
428,849
-150,595
-26% -$28.8M 1.67% 18
2019
Q1 		$114M Buy
+579,444
New +$104M 2.53% 6
2015
Q2 		– Sell
-717,374
Closed -$68M – 107
2015
Q1 		$66.2M Sell
717,374
-479,404
-40% -$44.6M 1.82% 20
2014
Q4 		$113M Buy
+1,196,778
New +$106M 2.64% 8

Other funds holding SYK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PFM Health Sciences's SYK Position: Q2 2026 in Review

PFM Health Sciences increased its Stryker (SYK) stake by 158% in Q2 2026, buying an estimated $10.9M and bringing the position to 56,637 shares worth $17.8M. The position accounts for 1.53% of the portfolio, ranked #17.

PFM Health Sciences first reported a position in SYK in Q4 2014 and has held it in 15 quarters since. The position peaked at $114M in Q1 2019. 2,259 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • PFM Health Sciences held 56,637 shares of Stryker worth $17.8M as of Q2 2026.
  • PFM Health Sciences bought 34,680 Stryker shares in Q2 2026, an estimated $10.9M.
  • Stryker made up 1.53% of PFM Health Sciences's portfolio in Q2 2026, its #17 holding.
  • PFM Health Sciences first reported a position in Stryker in Q4 2014 and has held it in 15 quarters since.
  • PFM Health Sciences's Stryker position peaked at $114M in Q1 2019.
  • 2,259 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.